Cite

HARVARD Citation

    Garros-Regulez, L. et al. (n.d.). MTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance. Expert opinion on therapeutic targets. pp. 393-405. [Online]. 
  
Back to record